SHIN NIPPON BIOMEDICAL LABORATORIES financial statements, including revenue, expenses, profit, and loss
The total revenue of 2395 for the last quarter is 6.10 B JPY, and it's 0.36% higher compared to the previous quarter. The net income of Q3 23 is 828.48 M JPY.